Epidemiology of Metastatic Castration-Resistant Prostate Cancer in Veterans Nationwide
This study describes veterans with mCRPC, suggests that survival and diagnostic methods are improving, and emphasizes the need for better disease management strategies to delay progression to and enhance treatment of mCRPC in order to further prolong survival.
Authors
- Nai-Chung Chang (ORCID: https://orcid.org/0000-0002-4541-8967)
- Camilla B. Pimentel
- Danielle Candelieri-Surette (ORCID: https://orcid.org/0009-0008-8750-6720)
- Julie Ann Lynch (ORCID: https://orcid.org/0000-0003-0108-2127)
- Martin William Schoen (ORCID: https://orcid.org/0000-0001-6388-5553)
- Dan R. Berlowitz (ORCID: https://orcid.org/0000-0002-8783-5611)
- Craig C. Teerlink (ORCID: https://orcid.org/0000-0002-1992-2326)
- Tyler J. Nelson (ORCID: https://orcid.org/0000-0001-5216-7337)
- Jong‐Soo Lee (ORCID: https://orcid.org/0000-0001-5119-0711)
Institutions
- Boston University (US)
- University of Massachusetts Lowell (US)
- University of Utah (US)
- VA Salt Lake City Healthcare System (US)
- VA New England Healthcare System (US)
- VA St. Louis Health Care System (US)
- Saint Louis University (US)
Publication Details
- Journal
- Journal of the National Comprehensive Cancer Network
- Published
- 2025-07-14
- DOI
- https://doi.org/10.6004/jnccn.2025.7032
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00